Shawn Williams, Abiel Obanjo, and Dr. Elizabeth Jackson, the young African American founders of Divergent CRO, a leading Black-owned provider of clinical services to biotech and device companies, are pleased to announce the official launch of their firm’s new Contract Research Organization (CRO). Based in Atlanta, Georgia, this new venture aims to revolutionize the research and development process by offering comprehensive and tailored clinical services to meet the unique diversity needs of the biotech and device industries.
With an unwavering commitment to excellence, Divergent CRO provides a wide range of services, including clinical trial management, regulatory affairs, data management, biostatistics, and medical writing. By leveraging our extensive expertise, we are dedicated to helping our clients accelerate the development of innovative biopharmaceuticals and medical devices.
Their team of highly skilled professionals, including experienced clinical researchers, project managers, and regulatory specialists, is dedicated to delivering the highest standards of quality and efficiency throughout each stage of the clinical trial process. We understand the challenges faced by biotech and device companies and are committed to providing flexible and cost-effective solutions to meet their specific needs.
Divergent CRO is equipped with cutting-edge technology and infrastructure to ensure the smooth execution of clinical trials. Its advanced data management systems and secure facilities ensure the confidentiality and integrity of study data, while our robust quality assurance processes guarantee compliance with regulatory requirements.
“We are thrilled to launch our new Contract Research Organization and partner with biotech and device companies to advance the development of life-changing therapies,” said Abiel Obanjo, partner and co-founder of the firm. “Our team is dedicated to delivering exceptional results and providing the highest level of service to our clients. With our expertise and commitment to excellence, we are confident that we can make a significant impact on the success of their clinical programs.”
Divergent CRO is now accepting inquiries and is available to discuss collaboration opportunities with biotech and device companies seeking to enhance their clinical research capabilities. For more information, please visit its official website at Divergentcro.com
Divergent CRO is one of the few Black-owned leading providers of clinical services to biotech and device companies. With a focus on innovation and quality, it strives to accelerate the development of life-changing therapies through our comprehensive and tailored clinical services. It thrives on leaving its clients and patients satisfied by improving human health and wellness. Their team of experts is dedicated to delivering exceptional results and providing the highest level of service to our clients. At Divergent CRO, they don’t just manage clinical trials; they craft personalized solutions, striving to be the difference by transforming challenges into triumphs in the pursuit of groundbreaking healthcare innovation.
For press release inquiries or business development, contact Customerservice@divergentcro.com or (888) 342-1447.